Article

More than just cancer awareness

This weekend I'm participating in the North Mississippi Komen for the Cure 5K. I've set myself a goal for five 5Ks this year. I've completed one for lung cancer, melanoma and a non-cancer related event for good measure (Habitat for Humanity). I'm considering finishing up the year doing one for St. Jude's in Memphis. By participating in the Komen race this Saturday, I'm raising awareness of breast cancer. But more importantly, I'm doing something to help prevent it. I'm exercising. A study recently presented at the AACR International Conference on Frontiers in Cancer Prevention Research found that exercise reduces the chance of developing invasive breast cancer (Physical Activity Cuts Risk for Invasive Breast Cancer). We've heard this before, but this is one of the largest trials to study the effect. It appears that exercise has the biggest impact in postmenopausal women and hormone-positive breast cancers. Like everything else, there are still other factors that play into breast cancer development, of course. Some of the fittest people I know have had breast cancer. But if it helps to reduce that risk and it comes with added benefits, why not?

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content